ASCO18: Celgene makes its case as CAR-T rival in lymphoma – BioPharma Dive
|
ASCO18: Celgene makes its case as CAR–T rival in lymphoma
BioPharma Dive Celgene’s experimental cell therapy JCAR017, or liso-cel, could prove competitive in lymphoma with already on-market treatments from Gilead and Novartis, suggest updated clinical results presented Sunday at the annual meeting of the American Society of … |
CTV News |
Edmonton family holds swab event in Calgary to find stem cell donor
CTV News Back in January, Bille Nguyen was diagnosed with a rare type of blood cancer that specialists say could be helped through a special treatment using a stem cell donation. The problem is that because Nguyen is Asian, there aren’t enough donors in the … |
STAT |
ASCO in 30: Immunotherapy controversy & less is just as good
STAT Sharon covers science and discovery. sharon.begley@statnews.com 3. @sxbegle 4. Adam Feuerstein 5. Senior Writer, Biotech. Adam is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. |
Pain News Network |
Taking Stem Cells to the Bank
Pain News Network There’s a lot of hope and hype surrounding stem cells – the latest being the idea of “banking” them — harvesting and storing your own stem cells for future use. A biotech start-up called Forever Labs maintains that young adults have healthier cells … |